HUTCHMED (China) HMDCF
NASDAQ HMDCF
$2.16 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

HUTCHMED (China) (HMDCF) Inventory (2015 - 2026)

HUTCHMED (China)'s (HMDCF) quarterly Inventory came in at $40.8 million in Q2 2026, down 15.71% year-over-year from $48.5 million in Q2 2025, and down 0.7% quarter-over-quarter from $41.1 million in Q4 2025.

Analysis

HUTCHMED (China) (HMDCF) Inventory (2015 - 2026) Analysis & Trends

HUTCHMED (China) (HMDCF) has reported Inventory for 12 consecutive years, with $40.8 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Inventory fell 15.71% year-over-year to $40.8 million in Q2 2026; TTM through Jun 2026 was $40.8 million, a 15.71% decrease from a year earlier, with the FY2025 full-year figure at $41.1 million, changed N/A from the prior year.
  • Inventory was $40.8 million for Q2 2026 at HUTCHMED (China), down from $41.1 million in the prior quarter.
  • Over five years, Inventory peaked at $56.7 million in Q4 2022 and troughed at $40.8 million in Q2 2026.
  • A 5-year average of $47.6 million and a median of $46.4 million in 2024 frame the typical range for Inventory.
  • Across the five-year window, Inventory surged 80.06% in 2022 and slipped 15.71% in 2026, its largest moves.
  • Over 5 years, Inventory stood at $56.7 million in 2022, then fell by 4.97% to $53.9 million in 2023, then dropped by 13.8% to $46.4 million in 2024, then declined by 11.44% to $41.1 million in 2025, then dropped by 0.7% to $40.8 million in 2026.
  • The last three Inventory figures came in at $40.8 million (Q2 2026), $41.1 million (Q4 2025), and $48.5 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory (Qtr)
1 Amgen 211.50 Bn 197.51 Bn 7.24 Bn 6.22 Bn
2 Gilead Sciences 181.29 Bn 178.11 Bn 6.22 Bn 1.95 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn 1.77 Bn
4 Regeneron Pharmaceuticals 82.55 Bn 74.56 Bn 3.93 Bn 3.08 Bn
5 Argenx Se 61.65 Bn 56.47 Bn 1.37 Bn 371.00 Mn
6 Moderna 54.65 Bn 49.52 Bn 52.00 Mn 280.00 Mn
7 Alnylam Pharmaceuticals 34.18 Bn 30.87 Bn 992.69 Mn 97.11 Mn
8 Biogen 31.36 Bn 30.07 Bn 1.96 Bn 2.38 Bn
9 Roivant Sciences 30.01 Bn 30.01 Bn 1.16 Mn -
10 HUTCHMED (China) 376.85 Mn 391.04 Mn - 40.84 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 40.84 Mn
Dec 31, 2025 41.13 Mn
Jun 30, 2025 48.45 Mn
Jun 30, 2024 46.44 Mn
Jun 30, 2023 53.88 Mn
Dec 31, 2022 56.69 Mn
Jun 30, 2022 45.93 Mn
Dec 31, 2021 35.76 Mn
Jun 30, 2021 25.51 Mn
Mar 31, 2021 19.76 Mn
Dec 31, 2020 19.77 Mn
Jun 30, 2020 15.26 Mn
Dec 31, 2019 16.21 Mn
Sep 30, 2019 15.65 Mn
Jun 30, 2019 14.22 Mn
Mar 31, 2019 17.61 Mn
Dec 31, 2018 557,000.00
Jun 30, 2018 9.79 Mn
Dec 31, 2017 1.05 Mn
Jun 30, 2017 10.69 Mn